| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.005 |